SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 174 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $7,000 | -36.4% | 15,826 | +12.8% | 0.00% | – |
Q2 2022 | $11,000 | -82.0% | 14,025 | -70.5% | 0.00% | – |
Q1 2022 | $61,000 | -24.7% | 47,538 | -25.5% | 0.00% | – |
Q4 2021 | $81,000 | -38.2% | 63,845 | +6.1% | 0.00% | – |
Q3 2021 | $131,000 | -52.5% | 60,176 | -18.2% | 0.00% | -100.0% |
Q2 2021 | $276,000 | +34.0% | 73,595 | +16.7% | 0.00% | 0.0% |
Q1 2021 | $206,000 | +5.6% | 63,046 | +10.1% | 0.00% | 0.0% |
Q4 2020 | $195,000 | +8.9% | 57,273 | +30.8% | 0.00% | 0.0% |
Q3 2020 | $179,000 | +46.7% | 43,797 | +21.0% | 0.00% | 0.0% |
Q2 2020 | $122,000 | +117.9% | 36,202 | +51.4% | 0.00% | – |
Q1 2020 | $56,000 | -63.9% | 23,919 | -43.9% | 0.00% | -100.0% |
Q4 2019 | $155,000 | -59.4% | 42,649 | -7.5% | 0.00% | -50.0% |
Q3 2019 | $382,000 | -4.5% | 46,103 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $400,000 | -27.7% | 46,416 | -10.3% | 0.00% | -33.3% |
Q1 2019 | $553,000 | +27.1% | 51,724 | +4.1% | 0.00% | 0.0% |
Q4 2018 | $435,000 | -55.4% | 49,700 | -14.4% | 0.00% | -57.1% |
Q3 2018 | $975,000 | -22.2% | 58,041 | -2.9% | 0.01% | -12.5% |
Q2 2018 | $1,253,000 | +28.8% | 59,798 | -1.1% | 0.01% | +33.3% |
Q1 2018 | $973,000 | -26.5% | 60,456 | -13.5% | 0.01% | -33.3% |
Q4 2017 | $1,324,000 | +72.8% | 69,884 | +28.4% | 0.01% | +28.6% |
Q3 2017 | $766,000 | +108.7% | 54,430 | +10.6% | 0.01% | +75.0% |
Q2 2017 | $367,000 | +5.5% | 49,211 | -8.1% | 0.00% | 0.0% |
Q1 2017 | $348,000 | +16.8% | 53,568 | -20.3% | 0.00% | +33.3% |
Q4 2016 | $298,000 | +7.2% | 67,226 | +13.0% | 0.00% | -25.0% |
Q3 2016 | $278,000 | -30.7% | 59,478 | -2.6% | 0.00% | -20.0% |
Q2 2016 | $401,000 | +5.0% | 61,073 | +1.8% | 0.01% | 0.0% |
Q1 2016 | $382,000 | -3.0% | 60,019 | -8.2% | 0.01% | 0.0% |
Q4 2015 | $394,000 | +11.9% | 65,378 | +11.1% | 0.01% | 0.0% |
Q3 2015 | $352,000 | -18.3% | 58,837 | -6.7% | 0.01% | -16.7% |
Q2 2015 | $431,000 | +5.6% | 63,053 | -6.2% | 0.01% | +20.0% |
Q1 2015 | $408,000 | 0.0% | 67,209 | +14.1% | 0.01% | 0.0% |
Q4 2014 | $408,000 | -18.1% | 58,908 | -3.7% | 0.01% | -28.6% |
Q3 2014 | $498,000 | -16.9% | 61,173 | -17.0% | 0.01% | -12.5% |
Q2 2014 | $599,000 | -33.1% | 73,683 | -35.5% | 0.01% | -27.3% |
Q1 2014 | $896,000 | +202.7% | 114,250 | +241.7% | 0.01% | +175.0% |
Q4 2013 | $296,000 | -44.6% | 33,439 | -47.4% | 0.00% | -69.2% |
Q3 2013 | $534,000 | +36.9% | 63,593 | +21.7% | 0.01% | +62.5% |
Q2 2013 | $390,000 | – | 52,238 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |